2.400CAD0.00%Mkt Cap: 4.46M $P/E: —49d ago
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kin…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap4.46M $
Enterprise Value27.71M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.55M $
Revenue/Share—
Last Price2.400 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.79
PEG—
EV/EBITDA-1.44
EV/Revenue—
P/S—
P/B—
EPS (TTM)-14.78
EPS (Forward)-3.05
52W Range
1.08087% of range2.590
52W High2.590 CAD
52W Low1.080 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE93.75%
ROA-254.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.01M $
CapEx (TTM)—
FCF Margin—
FCF Yield-237.70%
Net Debt23.25M $
Net Debt/EBITDA-1.21
Balance Sheet
Debt/Equity-1.03
Current Ratio0.55
Quick Ratio0.09
Book Value/Sh-19.2968 CAD
Cash/Share0.4000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateFeb 26, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.55M
Float320.61K
Insiders107.43%
Institutions3.91%
Short Interest
Short Ratio0.0d
Short % Float0.01%
Short % Out.0.00%
Shares Short112
Short (prev mo.)946
Technical
SMA 502.255 (+6.4%)
SMA 2002.140 (+12.2%)
Beta0.34
S&P 52W Chg18.16%
Avg Vol (30d)3.57K
Avg Vol (10d)4.11K
Technical Indicators
RSI (14)60.2
MACD0.0058
MACD Signal-0.0178
MACD Hist.+0.0236
BB Upper2.388 CAD
BB Middle2.224 CAD
BB Lower2.059 CAD
BB Width14.81%
ATR (14)0.0670 CAD
Vol Ratio (20d)0.65x